A detailed history of Norden Group LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Norden Group LLC holds 249,732 shares of ZTS stock, worth $42.3 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
249,732
Previous 6,469 3760.44%
Holding current value
$42.3 Million
Previous $1.28 Billion 3209.35%
% of portfolio
0.47%
Previous 0.22%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$165.67 - $199.94 $39.4 Million - $47.6 Million
-237,887 Reduced 95.26%
11,845 $2 Billion
Q1 2024

Apr 19, 2024

BUY
$165.67 - $199.94 $40.3 Million - $48.6 Million
243,263 Added 3760.44%
249,732 $42.3 Billion
Q4 2023

Feb 05, 2024

SELL
$151.44 - $200.09 $119,940 - $158,471
-792 Reduced 10.91%
6,469 $1.28 Billion
Q3 2023

Nov 06, 2023

BUY
$167.14 - $192.77 $1.21 Million - $1.4 Million
7,261 New
7,261 $1.26 Billion

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $79.4B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Norden Group LLC Portfolio

Follow Norden Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norden Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Norden Group LLC with notifications on news.